BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22112968)

  • 1. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
    He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
    Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
    He XX; Tu SM; Lee MH; Yeung SJ
    Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
    Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
    Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.
    Kim HJ; Kwon H; Lee JW; Kim HJ; Lee SB; Park HS; Sohn G; Lee Y; Koh BS; Yu JH; Son BH; Ahn SH
    Breast Cancer Res; 2015 May; 17(1):64. PubMed ID: 25935404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
    Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
    Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and survival in diabetic patients with breast cancer.
    El-Benhawy SA; El-Sheredy HG
    J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
    Bowker SL; Lin M; Eurich DT; Johnson JA
    Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma.
    Wu W; Merriman K; Nabaah A; Seval N; Seval D; Lin H; Wang M; Qazilbash MH; Baladandayuthapani V; Berry D; Orlowski RZ; Lee MH; Yeung SC
    Br J Cancer; 2014 Jul; 111(3):628-36. PubMed ID: 24921909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.
    Sonnenblick A; Agbor-Tarh D; Bradbury I; Di Cosimo S; Azim HA; Fumagalli D; Sarp S; Wolff AC; Andersson M; Kroep J; Cufer T; Simon SD; Salman P; Toi M; Harris L; Gralow J; Keane M; Moreno-Aspitia A; Piccart-Gebhart M; de Azambuja E
    J Clin Oncol; 2017 May; 35(13):1421-1429. PubMed ID: 28375706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.
    Yam C; Esteva FJ; Patel MM; Raghavendra AS; Ueno NT; Moulder SL; Hess KR; Shroff GS; Hodge S; Koenig KH; Chavez Mac Gregor M; Griner RL; Yeung SJ; Hortobagyi GN; Valero V
    Invest New Drugs; 2019 Apr; 37(2):345-351. PubMed ID: 30610588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
    Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
    Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
    Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin.
    Berstein LM; Boyarkina MP; Tsyrlina EV; Turkevich EA; Semiglazov VF
    Med Oncol; 2011 Dec; 28(4):1260-3. PubMed ID: 20490716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study.
    Yang J; Vallarino C; Bron M; Perez A; Liang H; Joseph G; Yu S
    Curr Med Res Opin; 2014 Nov; 30(11):2223-31. PubMed ID: 24983744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
    Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
    Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.
    Gosmanova EO; Canada RB; Mangold TA; Rawls WN; Wall BM
    Am J Med Sci; 2008 Sep; 336(3):241-7. PubMed ID: 18794619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
    Zhou JB; Tang X; Han M; Yang J; Simó R
    Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
    Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
    Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.